These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3760112)

  • 21. Pharmacological control of osteoclastic motility.
    Chambers TJ; Dunn CJ
    Calcif Tissue Int; 1983 Jul; 35(4-5):566-70. PubMed ID: 6311380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time course of "escape" from calcitonin-induced inhibition of motility and resorption of disaggregated osteoclasts.
    Kanehisa J
    Bone; 1989; 10(2):125-9. PubMed ID: 2765310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures.
    Hattersley G; Chambers TJ
    Endocrinology; 1989 Sep; 125(3):1606-12. PubMed ID: 2547591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early responses by osteoclasts in vivo and dentinoclasts in vitro to corticosteroids.
    Pierce AM; Lindskog S
    J Submicrosc Cytol Pathol; 1989 Jul; 21(3):501-8. PubMed ID: 2790732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex shape changes in isolated rat osteoclasts: involvement of protein kinase C in the response to calcitonin.
    Holloway WR; Collier FM; Herbst RE; Hodge JM; Nicholson GC
    Calcif Tissue Int; 1997 Oct; 61(4):306-12. PubMed ID: 9312201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of prostaglandins I2, E1, E2 and dibutyryl cyclic AMP on the cytoplasmic spreading of rat osteoclasts.
    Chambers TJ; Fuller K; Athanasou NA
    Br J Exp Pathol; 1984 Oct; 65(5):557-66. PubMed ID: 6091728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro.
    D'Souza SM; MacIntyre I; Girgis SI; Mundy GR
    Endocrinology; 1986 Jul; 119(1):58-61. PubMed ID: 3487444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological activity of chicken calcitonin: effects on neonatal rat and embryonic chick osteoclasts.
    Dempster DW; Murrills RJ; Horbert WR; Arnett TR
    J Bone Miner Res; 1987 Oct; 2(5):443-8. PubMed ID: 3455627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal regulation of acid phosphatase release by osteoclasts disaggregated from neonatal rat bone.
    Chambers TJ; Fuller K; Darby JA
    J Cell Physiol; 1987 Jul; 132(1):90-6. PubMed ID: 3597555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of calcitonin gene-related peptide on bone resorption mediated by interleukin-1.
    Zhang WZ; Yu SF; Zheng LF
    Chin Med J (Engl); 1994 May; 107(5):351-4. PubMed ID: 7924575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pH on bone resorption by rat osteoclasts in vitro.
    Arnett TR; Dempster DW
    Endocrinology; 1986 Jul; 119(1):119-24. PubMed ID: 3720660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cytoplasmic calcium concentration in tetracycline-treated osteoclasts.
    Donahue HJ; Iijima K; Goligorsky MS; Rubin CT; Rifkin BR
    J Bone Miner Res; 1992 Nov; 7(11):1313-8. PubMed ID: 1466256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
    Samura A; Wada S; Suda S; Iitaka M; Katayama S
    Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro.
    Feldman RS; Krieger NS; Tashjian AH
    Endocrinology; 1980 Oct; 107(4):1137-43. PubMed ID: 7408763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human calcitonin has the same inhibitory effect on osteoclastic bone resorption by human giant cell tumor cells as salmon calcitonin.
    Iida S; Kakudo S; Mori Y; Matsui M; Magota K; Kitajima Y; Nakamura N; Mano H; Hakeda Y; Azuma H; Kurokawa T; Kumegawa M
    Calcif Tissue Int; 1996 Aug; 59(2):100-4. PubMed ID: 8687977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
    Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
    Endocrinology; 1996 Mar; 137(3):1042-8. PubMed ID: 8603572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced potency of human calcitonin when fibrillation is avoided.
    Cudd A; Arvinte T; Das RE; Chinni C; MacIntyre I
    J Pharm Sci; 1995 Jun; 84(6):717-9. PubMed ID: 7562410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone.
    McSheehy PM; Chambers TJ
    Endocrinology; 1986 Feb; 118(2):824-8. PubMed ID: 3455914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.
    McSheehy PM; Chambers TJ
    J Clin Invest; 1987 Aug; 80(2):425-9. PubMed ID: 3611354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue.
    Delaisse JM; Eeckhout Y; Vaes G
    Endocrinology; 1988 Jul; 123(1):264-76. PubMed ID: 2838255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.